Global Rasagiline Tablet Market Insights, Forecast to 2029

Global Rasagiline Tablet Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Rasagiline Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Rasagiline Tablet Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 0.5 mg/Pcs
1.2.3 1 mg/Pcs
1.3 Market by Application
1.3.1 Global Rasagiline Tablet Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rasagiline Tablet Sales Estimates and Forecasts 2018-2029
2.2 Global Rasagiline Tablet Revenue by Region
2.2.1 Global Rasagiline Tablet Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Rasagiline Tablet Revenue by Region (2018-2023)
2.2.3 Global Rasagiline Tablet Revenue by Region (2024-2029)
2.2.4 Global Rasagiline Tablet Revenue Market Share by Region (2018-2029)
2.3 Global Rasagiline Tablet Sales Estimates and Forecasts 2018-2029
2.4 Global Rasagiline Tablet Sales by Region
2.4.1 Global Rasagiline Tablet Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Rasagiline Tablet Sales by Region (2018-2023)
2.4.3 Global Rasagiline Tablet Sales by Region (2024-2029)
2.4.4 Global Rasagiline Tablet Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rasagiline Tablet Sales by Manufacturers
3.1.1 Global Rasagiline Tablet Sales by Manufacturers (2018-2023)
3.1.2 Global Rasagiline Tablet Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rasagiline Tablet in 2022
3.2 Global Rasagiline Tablet Revenue by Manufacturers
3.2.1 Global Rasagiline Tablet Revenue by Manufacturers (2018-2023)
3.2.2 Global Rasagiline Tablet Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Rasagiline Tablet Revenue in 2022
3.3 Global Key Players of Rasagiline Tablet, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Rasagiline Tablet Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rasagiline Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rasagiline Tablet, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rasagiline Tablet, Product Offered and Application
3.8 Global Key Manufacturers of Rasagiline Tablet, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rasagiline Tablet Sales by Type
4.1.1 Global Rasagiline Tablet Historical Sales by Type (2018-2023)
4.1.2 Global Rasagiline Tablet Forecasted Sales by Type (2024-2029)
4.1.3 Global Rasagiline Tablet Sales Market Share by Type (2018-2029)
4.2 Global Rasagiline Tablet Revenue by Type
4.2.1 Global Rasagiline Tablet Historical Revenue by Type (2018-2023)
4.2.2 Global Rasagiline Tablet Forecasted Revenue by Type (2024-2029)
4.2.3 Global Rasagiline Tablet Revenue Market Share by Type (2018-2029)
4.3 Global Rasagiline Tablet Price by Type
4.3.1 Global Rasagiline Tablet Price by Type (2018-2023)
4.3.2 Global Rasagiline Tablet Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Rasagiline Tablet Sales by Application
5.1.1 Global Rasagiline Tablet Historical Sales by Application (2018-2023)
5.1.2 Global Rasagiline Tablet Forecasted Sales by Application (2024-2029)
5.1.3 Global Rasagiline Tablet Sales Market Share by Application (2018-2029)
5.2 Global Rasagiline Tablet Revenue by Application
5.2.1 Global Rasagiline Tablet Historical Revenue by Application (2018-2023)
5.2.2 Global Rasagiline Tablet Forecasted Revenue by Application (2024-2029)
5.2.3 Global Rasagiline Tablet Revenue Market Share by Application (2018-2029)
5.3 Global Rasagiline Tablet Price by Application
5.3.1 Global Rasagiline Tablet Price by Application (2018-2023)
5.3.2 Global Rasagiline Tablet Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Rasagiline Tablet Market Size by Type
6.1.1 US & Canada Rasagiline Tablet Sales by Type (2018-2029)
6.1.2 US & Canada Rasagiline Tablet Revenue by Type (2018-2029)
6.2 US & Canada Rasagiline Tablet Market Size by Application
6.2.1 US & Canada Rasagiline Tablet Sales by Application (2018-2029)
6.2.2 US & Canada Rasagiline Tablet Revenue by Application (2018-2029)
6.3 US & Canada Rasagiline Tablet Market Size by Country
6.3.1 US & Canada Rasagiline Tablet Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Rasagiline Tablet Sales by Country (2018-2029)
6.3.3 US & Canada Rasagiline Tablet Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rasagiline Tablet Market Size by Type
7.1.1 Europe Rasagiline Tablet Sales by Type (2018-2029)
7.1.2 Europe Rasagiline Tablet Revenue by Type (2018-2029)
7.2 Europe Rasagiline Tablet Market Size by Application
7.2.1 Europe Rasagiline Tablet Sales by Application (2018-2029)
7.2.2 Europe Rasagiline Tablet Revenue by Application (2018-2029)
7.3 Europe Rasagiline Tablet Market Size by Country
7.3.1 Europe Rasagiline Tablet Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Rasagiline Tablet Sales by Country (2018-2029)
7.3.3 Europe Rasagiline Tablet Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rasagiline Tablet Market Size
8.1.1 China Rasagiline Tablet Sales (2018-2029)
8.1.2 China Rasagiline Tablet Revenue (2018-2029)
8.2 China Rasagiline Tablet Market Size by Application
8.2.1 China Rasagiline Tablet Sales by Application (2018-2029)
8.2.2 China Rasagiline Tablet Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rasagiline Tablet Market Size by Type
9.1.1 Asia Rasagiline Tablet Sales by Type (2018-2029)
9.1.2 Asia Rasagiline Tablet Revenue by Type (2018-2029)
9.2 Asia Rasagiline Tablet Market Size by Application
9.2.1 Asia Rasagiline Tablet Sales by Application (2018-2029)
9.2.2 Asia Rasagiline Tablet Revenue by Application (2018-2029)
9.3 Asia Rasagiline Tablet Sales by Region
9.3.1 Asia Rasagiline Tablet Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Rasagiline Tablet Revenue by Region (2018-2029)
9.3.3 Asia Rasagiline Tablet Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rasagiline Tablet Market Size by Type
10.1.1 Middle East, Africa and Latin America Rasagiline Tablet Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Rasagiline Tablet Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Rasagiline Tablet Market Size by Application
10.2.1 Middle East, Africa and Latin America Rasagiline Tablet Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Rasagiline Tablet Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Rasagiline Tablet Sales by Country
10.3.1 Middle East, Africa and Latin America Rasagiline Tablet Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Rasagiline Tablet Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Rasagiline Tablet Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Information
11.1.2 Teva Pharmaceutical Overview
11.1.3 Teva Pharmaceutical Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Teva Pharmaceutical Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Pharmaceutical Recent Developments
11.2 Lundbeck
11.2.1 Lundbeck Company Information
11.2.2 Lundbeck Overview
11.2.3 Lundbeck Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Lundbeck Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lundbeck Recent Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Information
11.3.2 Sun Pharmaceutical Overview
11.3.3 Sun Pharmaceutical Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Sun Pharmaceutical Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharmaceutical Recent Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Overview
11.4.3 Apotex Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Apotex Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Recent Developments
11.5 Taj Pharma
11.5.1 Taj Pharma Company Information
11.5.2 Taj Pharma Overview
11.5.3 Taj Pharma Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Taj Pharma Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Taj Pharma Recent Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Overview
11.6.3 Mylan Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Mylan Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan Recent Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Information
11.7.2 Takeda Pharmaceutical Overview
11.7.3 Takeda Pharmaceutical Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Takeda Pharmaceutical Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Takeda Pharmaceutical Recent Developments
11.8 Sandoz
11.8.1 Sandoz Company Information
11.8.2 Sandoz Overview
11.8.3 Sandoz Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Sandoz Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sandoz Recent Developments
11.9 Intas Pharmaceuticals
11.9.1 Intas Pharmaceuticals Company Information
11.9.2 Intas Pharmaceuticals Overview
11.9.3 Intas Pharmaceuticals Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Intas Pharmaceuticals Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Intas Pharmaceuticals Recent Developments
11.10 Natco Pharma
11.10.1 Natco Pharma Company Information
11.10.2 Natco Pharma Overview
11.10.3 Natco Pharma Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Natco Pharma Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Natco Pharma Recent Developments
11.11 Ajanta Pharma
11.11.1 Ajanta Pharma Company Information
11.11.2 Ajanta Pharma Overview
11.11.3 Ajanta Pharma Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Ajanta Pharma Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Ajanta Pharma Recent Developments
11.12 Orchid Pharma
11.12.1 Orchid Pharma Company Information
11.12.2 Orchid Pharma Overview
11.12.3 Orchid Pharma Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Orchid Pharma Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Orchid Pharma Recent Developments
11.13 Alkem Laboratories
11.13.1 Alkem Laboratories Company Information
11.13.2 Alkem Laboratories Overview
11.13.3 Alkem Laboratories Rasagiline Tablet Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Alkem Laboratories Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Alkem Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rasagiline Tablet Industry Chain Analysis
12.2 Rasagiline Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rasagiline Tablet Production Mode & Process
12.4 Rasagiline Tablet Sales and Marketing
12.4.1 Rasagiline Tablet Sales Channels
12.4.2 Rasagiline Tablet Distributors
12.5 Rasagiline Tablet Customers
13 Market Dynamics
13.1 Rasagiline Tablet Industry Trends
13.2 Rasagiline Tablet Market Drivers
13.3 Rasagiline Tablet Market Challenges
13.4 Rasagiline Tablet Market Restraints
14 Key Findings in The Global Rasagiline Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Rasagiline Tablet Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 0.5 mg/Pcs
Table 3. Major Manufacturers of 1 mg/Pcs
Table 4. Global Rasagiline Tablet Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Rasagiline Tablet Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Rasagiline Tablet Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Rasagiline Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Rasagiline Tablet Revenue Market Share by Region (2018-2023)
Table 9. Global Rasagiline Tablet Revenue Market Share by Region (2024-2029)
Table 10. Global Rasagiline Tablet Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Rasagiline Tablet Sales by Region (2018-2023) & (M Pcs)
Table 12. Global Rasagiline Tablet Sales by Region (2024-2029) & (M Pcs)
Table 13. Global Rasagiline Tablet Sales Market Share by Region (2018-2023)
Table 14. Global Rasagiline Tablet Sales Market Share by Region (2024-2029)
Table 15. Global Rasagiline Tablet Sales by Manufacturers (2018-2023) & (M Pcs)
Table 16. Global Rasagiline Tablet Sales Share by Manufacturers (2018-2023)
Table 17. Global Rasagiline Tablet Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Rasagiline Tablet Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Rasagiline Tablet, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Rasagiline Tablet Price by Manufacturers 2018-2023 (USD/K Pcs)
Table 21. Global Rasagiline Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rasagiline Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rasagiline Tablet as of 2022)
Table 23. Global Key Manufacturers of Rasagiline Tablet, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Rasagiline Tablet, Product Offered and Application
Table 25. Global Key Manufacturers of Rasagiline Tablet, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 28. Global Rasagiline Tablet Sales by Type (2024-2029) & (M Pcs)
Table 29. Global Rasagiline Tablet Sales Share by Type (2018-2023)
Table 30. Global Rasagiline Tablet Sales Share by Type (2024-2029)
Table 31. Global Rasagiline Tablet Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Rasagiline Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Rasagiline Tablet Revenue Share by Type (2018-2023)
Table 34. Global Rasagiline Tablet Revenue Share by Type (2024-2029)
Table 35. Rasagiline Tablet Price by Type (2018-2023) & (USD/K Pcs)
Table 36. Global Rasagiline Tablet Price Forecast by Type (2024-2029) & (USD/K Pcs)
Table 37. Global Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 38. Global Rasagiline Tablet Sales by Application (2024-2029) & (M Pcs)
Table 39. Global Rasagiline Tablet Sales Share by Application (2018-2023)
Table 40. Global Rasagiline Tablet Sales Share by Application (2024-2029)
Table 41. Global Rasagiline Tablet Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Rasagiline Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Rasagiline Tablet Revenue Share by Application (2018-2023)
Table 44. Global Rasagiline Tablet Revenue Share by Application (2024-2029)
Table 45. Rasagiline Tablet Price by Application (2018-2023) & (USD/K Pcs)
Table 46. Global Rasagiline Tablet Price Forecast by Application (2024-2029) & (USD/K Pcs)
Table 47. US & Canada Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 48. US & Canada Rasagiline Tablet Sales by Type (2024-2029) & (M Pcs)
Table 49. US & Canada Rasagiline Tablet Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Rasagiline Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 52. US & Canada Rasagiline Tablet Sales by Application (2024-2029) & (M Pcs)
Table 53. US & Canada Rasagiline Tablet Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Rasagiline Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Rasagiline Tablet Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Rasagiline Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 59. US & Canada Rasagiline Tablet Sales by Country (2024-2029) & (M Pcs)
Table 60. Europe Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 61. Europe Rasagiline Tablet Sales by Type (2024-2029) & (M Pcs)
Table 62. Europe Rasagiline Tablet Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Rasagiline Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 65. Europe Rasagiline Tablet Sales by Application (2024-2029) & (M Pcs)
Table 66. Europe Rasagiline Tablet Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Rasagiline Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Rasagiline Tablet Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Rasagiline Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 72. Europe Rasagiline Tablet Sales by Country (2024-2029) & (M Pcs)
Table 73. China Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 74. China Rasagiline Tablet Sales by Type (2024-2029) & (M Pcs)
Table 75. China Rasagiline Tablet Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Rasagiline Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 78. China Rasagiline Tablet Sales by Application (2024-2029) & (M Pcs)
Table 79. China Rasagiline Tablet Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Rasagiline Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 82. Asia Rasagiline Tablet Sales by Type (2024-2029) & (M Pcs)
Table 83. Asia Rasagiline Tablet Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Rasagiline Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 86. Asia Rasagiline Tablet Sales by Application (2024-2029) & (M Pcs)
Table 87. Asia Rasagiline Tablet Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Rasagiline Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Rasagiline Tablet Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Rasagiline Tablet Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Rasagiline Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Rasagiline Tablet Sales by Region (2018-2023) & (M Pcs)
Table 93. Asia Rasagiline Tablet Sales by Region (2024-2029) & (M Pcs)
Table 94. Middle East, Africa and Latin America Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 95. Middle East, Africa and Latin America Rasagiline Tablet Sales by Type (2024-2029) & (M Pcs)
Table 96. Middle East, Africa and Latin America Rasagiline Tablet Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Rasagiline Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 99. Middle East, Africa and Latin America Rasagiline Tablet Sales by Application (2024-2029) & (M Pcs)
Table 100. Middle East, Africa and Latin America Rasagiline Tablet Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Rasagiline Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Rasagiline Tablet Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rasagiline Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 106. Middle East, Africa and Latin America Rasagiline Tablet Sales by Country (2024-2029) & (M Pcs)
Table 107. Teva Pharmaceutical Company Information
Table 108. Teva Pharmaceutical Description and Major Businesses
Table 109. Teva Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 110. Teva Pharmaceutical Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Teva Pharmaceutical Recent Developments
Table 112. Lundbeck Company Information
Table 113. Lundbeck Description and Major Businesses
Table 114. Lundbeck Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 115. Lundbeck Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Lundbeck Recent Developments
Table 117. Sun Pharmaceutical Company Information
Table 118. Sun Pharmaceutical Description and Major Businesses
Table 119. Sun Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 120. Sun Pharmaceutical Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sun Pharmaceutical Recent Developments
Table 122. Apotex Company Information
Table 123. Apotex Description and Major Businesses
Table 124. Apotex Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 125. Apotex Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Apotex Recent Developments
Table 127. Taj Pharma Company Information
Table 128. Taj Pharma Description and Major Businesses
Table 129. Taj Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 130. Taj Pharma Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Taj Pharma Recent Developments
Table 132. Mylan Company Information
Table 133. Mylan Description and Major Businesses
Table 134. Mylan Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 135. Mylan Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Mylan Recent Developments
Table 137. Takeda Pharmaceutical Company Information
Table 138. Takeda Pharmaceutical Description and Major Businesses
Table 139. Takeda Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 140. Takeda Pharmaceutical Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Takeda Pharmaceutical Recent Developments
Table 142. Sandoz Company Information
Table 143. Sandoz Description and Major Businesses
Table 144. Sandoz Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 145. Sandoz Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sandoz Recent Developments
Table 147. Intas Pharmaceuticals Company Information
Table 148. Intas Pharmaceuticals Description and Major Businesses
Table 149. Intas Pharmaceuticals Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 150. Intas Pharmaceuticals Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Intas Pharmaceuticals Recent Developments
Table 152. Natco Pharma Company Information
Table 153. Natco Pharma Description and Major Businesses
Table 154. Natco Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 155. Natco Pharma Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Natco Pharma Recent Developments
Table 157. Ajanta Pharma Company Information
Table 158. Ajanta Pharma Description and Major Businesses
Table 159. Ajanta Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 160. Ajanta Pharma Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Ajanta Pharma Recent Developments
Table 162. Orchid Pharma Company Information
Table 163. Orchid Pharma Description and Major Businesses
Table 164. Orchid Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 165. Orchid Pharma Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Orchid Pharma Recent Developments
Table 167. Alkem Laboratories Company Information
Table 168. Alkem Laboratories Description and Major Businesses
Table 169. Alkem Laboratories Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 170. Alkem Laboratories Rasagiline Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Alkem Laboratories Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Rasagiline Tablet Distributors List
Table 175. Rasagiline Tablet Customers List
Table 176. Rasagiline Tablet Market Trends
Table 177. Rasagiline Tablet Market Drivers
Table 178. Rasagiline Tablet Market Challenges
Table 179. Rasagiline Tablet Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Rasagiline Tablet Product Picture
Figure 2. Global Rasagiline Tablet Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rasagiline Tablet Market Share by Type in 2022 & 2029
Figure 4. 0.5 mg/Pcs Product Picture
Figure 5. 1 mg/Pcs Product Picture
Figure 6. Global Rasagiline Tablet Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Rasagiline Tablet Market Share by Application in 2022 & 2029
Figure 8. Under 40 Years Old
Figure 9. 40-65 Years Old
Figure 10. Above 65 Years Old
Figure 11. Rasagiline Tablet Report Years Considered
Figure 12. Global Rasagiline Tablet Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Rasagiline Tablet Revenue 2018-2029 (US$ Million)
Figure 14. Global Rasagiline Tablet Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Rasagiline Tablet Revenue Market Share by Region (2018-2029)
Figure 16. Global Rasagiline Tablet Sales 2018-2029 ((M Pcs)
Figure 17. Global Rasagiline Tablet Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Rasagiline Tablet Sales YoY (2018-2029) & (M Pcs)
Figure 19. US & Canada Rasagiline Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Rasagiline Tablet Sales YoY (2018-2029) & (M Pcs)
Figure 21. Europe Rasagiline Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Rasagiline Tablet Sales YoY (2018-2029) & (M Pcs)
Figure 23. China Rasagiline Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Rasagiline Tablet Sales YoY (2018-2029) & (M Pcs)
Figure 25. Asia (excluding China) Rasagiline Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Rasagiline Tablet Sales YoY (2018-2029) & (M Pcs)
Figure 27. Middle East, Africa and Latin America Rasagiline Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Rasagiline Tablet Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Rasagiline Tablet in the World: Market Share by Rasagiline Tablet Revenue in 2022
Figure 30. Global Rasagiline Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Rasagiline Tablet Sales Market Share by Type (2018-2029)
Figure 32. Global Rasagiline Tablet Revenue Market Share by Type (2018-2029)
Figure 33. Global Rasagiline Tablet Sales Market Share by Application (2018-2029)
Figure 34. Global Rasagiline Tablet Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Rasagiline Tablet Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Rasagiline Tablet Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Rasagiline Tablet Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Rasagiline Tablet Revenue Market Share by Application (2018-2029)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs